×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions for PROGENICS PHARMACEUTICALS INC (PGNX)

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PGNXPROGENICS PHARMACEUTICALS INCAltiva Management Inc.10% OwnerSep 09, 2019Buy$4.9972,023359,7338,011,733Sep 11, 2019, 01:32 PM
PGNXPROGENICS PHARMACEUTICALS INCMelkonian Ryan10% OwnerSep 05, 2019Buy$4.6243,520201,0971,928,520Sep 09, 2019, 06:14 PM
PGNXPROGENICS PHARMACEUTICALS INCMelkonian Ryan10% OwnerSep 09, 2019Buy$4.9421,480106,0961,950,000Sep 09, 2019, 06:14 PM
PGNXPROGENICS PHARMACEUTICALS INCAltiva Management Inc.10% OwnerSep 04, 2019Buy$4.51243,6141,098,5297,939,710Sep 05, 2019, 04:37 PM
PGNXPROGENICS PHARMACEUTICALS INCVENKATARAMAN BALAJI10% OwnerSep 03, 2019Buy$4.39277,4241,218,9187,696,096Sep 05, 2019, 04:37 PM
PGNXPROGENICS PHARMACEUTICALS INCVENKATARAMAN BALAJI10% OwnerAug 23, 2019Buy$4.31130,826563,6907,345,442Aug 27, 2019, 03:45 PM
PGNXPROGENICS PHARMACEUTICALS INCAltiva Management Inc.10% OwnerAug 26, 2019Buy$4.3073,230314,9117,418,672Aug 27, 2019, 03:45 PM
PGNXPROGENICS PHARMACEUTICALS INCCampbell Bradley LDirectorJul 03, 2019Option Exercise$4.8912,00058,68012,000Jul 08, 2019, 12:32 PM
PGNXPROGENICS PHARMACEUTICALS INCSCHEINBERG DAVID ADirectorJul 01, 2019Option Exercise$5.3310,00053,30056,185Jul 03, 2019, 08:56 AM
PGNXPROGENICS PHARMACEUTICALS INCCrowley Peter JDirectorJun 26, 2019Option Exercise$5.3550,000267,30050,000Jun 27, 2019, 04:33 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerFeb 13, 2017Sale$9.70100,000970,0007,499,869Feb 15, 2017, 05:13 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerFeb 14, 2017Sale$9.69352,6003,417,2207,447,269Feb 15, 2017, 05:13 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerFeb 15, 2017Sale$9.55150,0001,432,5006,997,269Feb 15, 2017, 05:13 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerFeb 09, 2017Sale$9.70201,3001,953,5907,701,169Feb 09, 2017, 04:40 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerFeb 07, 2017Sale$9.71150,0001,456,5007,851,169Feb 09, 2017, 04:40 PM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerJan 11, 2017Option Exercise$8.951,000,0008,950,0007,951,169Jan 13, 2017, 04:28 PM
PGNXPROGENICS PHARMACEUTICALS INCMADDON PAUL JDirectorDec 01, 2010Buy$4.905,00024,500909,891Apr 22, 2016, 05:09 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediJun 11, 2015Option Exercise$6.084,00024,32037,050Jun 15, 2015, 09:32 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediMar 13, 2015Option Exercise$6.176,00037,05038,050Mar 16, 2015, 12:26 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediMar 11, 2015Option Exercise$6.084,00024,32037,050Mar 13, 2015, 09:26 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediMar 03, 2015Option Exercise$5.5910,00055,95040,050Mar 04, 2015, 02:55 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediJan 12, 2015Option Exercise$6.194,00024,77237,050Jan 13, 2015, 01:48 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediDec 11, 2014Option Exercise$6.216,00037,25138,050Dec 12, 2014, 11:27 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediNov 21, 2014Option Exercise$6.1718,000111,15044,050Nov 21, 2014, 05:06 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediNov 13, 2014Sale$6.0820,000121,60045,050Nov 14, 2014, 04:38 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JExecutive Vice President, MediNov 11, 2014Sale$5.7810,00057,80040,050Nov 12, 2014, 09:31 AM
PGNXPROGENICS PHARMACEUTICALS INCKOTLER KEVIN10% OwnerJul 17, 2014Buy$4.48436,8841,957,2408,174,310Jul 23, 2014, 10:42 AM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Capital, LLC10% OwnerJul 18, 2014Buy$4.73388,2001,836,1868,562,510Jul 23, 2014, 10:42 AM
PGNXPROGENICS PHARMACEUTICALS INCKOTLER KEVIN10% OwnerJul 21, 2014Buy$4.73388,6591,838,3578,951,169Jul 23, 2014, 10:42 AM
PGNXPROGENICS PHARMACEUTICALS INCBroadfin Healthcare Master Fund Ltd10% OwnerJul 16, 2014Buy$4.48411,6931,844,3857,737,426Jul 23, 2014, 10:42 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJul 18, 2013Option Exercise$5.8310,00058,30040,050Jul 22, 2013, 01:16 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOMar 27, 2013Buy$5.326503,458161,141Mar 28, 2013, 09:24 AM
PGNXPROGENICS PHARMACEUTICALS INCSCHEINBERG DAVID ADirectorMar 22, 2013Option Exercise$3.642,5009,09847,435Mar 22, 2013, 05:14 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOFeb 27, 2013Buy$2.721,2623,434160,491Feb 28, 2013, 05:24 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJan 22, 2013Buy$2.821,2153,429159,229Jan 23, 2013, 09:59 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEODec 26, 2012Buy$3.011,1423,437158,014Dec 26, 2012, 01:05 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEONov 28, 2012Buy$2.131,6073,419156,872Nov 30, 2012, 12:07 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEONov 19, 2012Buy$1.9611,80023,104155,265Nov 20, 2012, 01:41 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEONov 16, 2012Buy$1.8249,79390,723143,465Nov 19, 2012, 01:50 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEONov 15, 2012Buy$1.6948,83382,33293,672Nov 16, 2012, 01:54 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOOct 24, 2012Buy$2.951,1623,43444,839Oct 25, 2012, 11:34 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOSep 26, 2012Buy$3.321,0363,44043,677Sep 27, 2012, 03:14 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOAug 22, 2012Buy$4.238153,45142,641Aug 23, 2012, 09:44 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJul 25, 2012Buy$10.043463,47341,826Jul 26, 2012, 11:42 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJul 02, 2012Sale$7.562,00015,12036,050Jul 03, 2012, 01:19 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJun 27, 2012Buy$9.273753,47741,480Jun 29, 2012, 09:15 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJun 20, 2012Option Exercise$8.583,33328,60435,050Jun 22, 2012, 03:01 PM
PGNXPROGENICS PHARMACEUTICALS INCOlson William CSenior VP, Research and DeveloJun 20, 2012Option Exercise$8.691,23010,68545,544Jun 22, 2012, 03:00 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJun 01, 2012Sale$6.922,00013,83839,383Jun 04, 2012, 04:49 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOMay 23, 2012Buy$7.814453,47541,105May 24, 2012, 12:38 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsMay 01, 2012Option Exercise$8.132,00016,25739,383May 03, 2012, 11:25 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOApr 25, 2012Buy$10.073483,50640,660Apr 27, 2012, 09:23 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsApr 02, 2012Sale$7.592,00015,18239,383Apr 03, 2012, 11:55 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOMar 28, 2012Buy$10.133433,47540,312Mar 29, 2012, 03:12 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsMar 01, 2012Option Exercise$7.572,00015,14739,383Mar 02, 2012, 04:29 PM
PGNXPROGENICS PHARMACEUTICALS INCSCHEINBERG DAVID ADirectorFeb 23, 2012Option Exercise$8.452,50021,12547,435Feb 27, 2012, 05:53 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOFeb 22, 2012Buy$9.413693,47439,969Feb 23, 2012, 09:28 AM
PGNXPROGENICS PHARMACEUTICALS INCBRINER KURT WDirectorFeb 03, 2012Sale$10.2233,000337,2270Feb 03, 2012, 05:48 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsFeb 01, 2012Sale$7.402,00014,80839,383Feb 02, 2012, 10:48 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJan 25, 2012Buy$9.533643,47039,600Jan 26, 2012, 10:05 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOOct 26, 2011Buy$6.525323,46738,211Jan 12, 2012, 01:16 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJan 11, 2012Buy$8.873913,46639,236Jan 12, 2012, 01:16 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJan 03, 2012Sale$7.052,00014,11039,383Jan 04, 2012, 01:24 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsDec 01, 2011Sale$5.992,00011,99039,383Dec 02, 2011, 02:57 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEONov 23, 2011Sale$5.456343,45538,313Nov 28, 2011, 02:18 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsNov 01, 2011Option Exercise$5.832,00011,66039,383Nov 01, 2011, 05:23 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsOct 05, 2011Sale$5.832,00011,66039,383Oct 05, 2011, 05:16 PM
PGNXPROGENICS PHARMACEUTICALS INCOlson William CSenior VP, Research and DeveloOct 03, 2011Option Exercise$5.014,96124,86249,130Oct 04, 2011, 05:24 PM
PGNXPROGENICS PHARMACEUTICALS INCMCKINNEY ROBERT ASenior VP, CFOOct 03, 2011Option Exercise$5.015,21226,12046,890Oct 04, 2011, 05:23 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsOct 03, 2011Option Exercise$5.016,92834,72041,673Oct 04, 2011, 05:22 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOOct 03, 2011Option Exercise$5.019,79049,07642,345Oct 04, 2011, 05:20 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOSep 28, 2011Buy$6.395423,46337,029Sep 28, 2011, 04:55 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsSep 27, 2011Sale$5.831,4928,69838,589Sep 28, 2011, 09:49 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsSep 20, 2011Sale$5.832001,16637,943Sep 21, 2011, 12:22 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsSep 01, 2011Option Exercise$5.833081,79637,997Sep 06, 2011, 02:11 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOAug 24, 2011Buy$6.085713,47236,487Aug 25, 2011, 09:31 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsAug 11, 2011Sale$5.832,00011,66038,843Aug 12, 2011, 11:31 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJul 27, 2011Buy$6.125673,47235,916Jul 28, 2011, 05:06 PM
PGNXPROGENICS PHARMACEUTICALS INCMCKINNEY ROBERT ASenior VP, CFOJul 01, 2011Option Exercise$6.3413,34184,60250,023Jul 06, 2011, 06:58 PM
PGNXPROGENICS PHARMACEUTICALS INCOlson William CSenior VP, Research and DeveloJul 01, 2011Option Exercise$6.3411,61173,63251,609Jul 06, 2011, 06:57 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJul 01, 2011Option Exercise$6.3317,252109,25544,773Jul 06, 2011, 06:55 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJul 01, 2011Option Exercise$6.3536,937234,47252,254Jul 06, 2011, 06:49 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOJun 22, 2011Buy$7.084903,46931,922Jun 24, 2011, 10:07 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJun 21, 2011Sale$7.017,88955,34136,151Jun 22, 2011, 04:54 PM
PGNXPROGENICS PHARMACEUTICALS INCOlson William CSenior VP, Research and DeveloJun 21, 2011Sale$7.092,87220,35945,080Jun 22, 2011, 04:53 PM
PGNXPROGENICS PHARMACEUTICALS INCMCKINNEY ROBERT ASenior VP, CFOJun 17, 2011Sale$7.503,00022,50042,444Jun 20, 2011, 11:27 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSenior VP Medical AffairsJun 01, 2011Option Exercise$6.742,00013,48345,040Jun 02, 2011, 03:08 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOMay 25, 2011Buy$7.134863,46531,432May 26, 2011, 03:15 PM
PGNXPROGENICS PHARMACEUTICALS INCBRINER KURT WDirectorMay 13, 2011Sale$8.2715,000123,97538,000May 17, 2011, 03:26 PM
PGNXPROGENICS PHARMACEUTICALS INCBRINER KURT WDirectorMay 16, 2011Sale$8.195,00040,92533,000May 17, 2011, 03:26 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSr. VP, Medical AffairsMay 02, 2011Sale$6.362,00012,72045,040May 04, 2011, 03:30 PM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertCEOApr 27, 2011Buy$7.244793,46830,946Apr 27, 2011, 04:05 PM
PGNXPROGENICS PHARMACEUTICALS INCMCKINNEY ROBERT AChief Financial OfficerApr 01, 2011Option Exercise$5.634,67626,31847,625Apr 05, 2011, 09:54 AM
PGNXPROGENICS PHARMACEUTICALS INCBaker Mark RobertPresidentApr 01, 2011Option Exercise$5.637,57242,64134,017Apr 05, 2011, 09:51 AM
PGNXPROGENICS PHARMACEUTICALS INCOlson William CSR. VP, Research & DevelopmentApr 01, 2011Option Exercise$5.634,44825,03549,921Apr 05, 2011, 09:50 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSr. VP, Medical AffairsApr 01, 2011Option Exercise$5.688,24546,80946,953Apr 05, 2011, 09:48 AM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSr. VP, Medical AffairsMar 29, 2011Sale$5.831,6009,32844,177Mar 30, 2011, 04:28 PM
PGNXPROGENICS PHARMACEUTICALS INCGOFF STEPHEN PDirectorMar 09, 2011Option Exercise$1.3332,50043,22566,000Mar 11, 2011, 05:25 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSr. VP, Medical AffairsMar 08, 2011Option Exercise$5.834002,33243,577Mar 09, 2011, 02:11 PM
PGNXPROGENICS PHARMACEUTICALS INCISRAEL ROBERT JSr. VP, Medical AffairsFeb 07, 2011Option Exercise$5.8315,19488,58150,974Feb 08, 2011, 04:31 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe